# Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery

> **NCT07740330** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Clinique Saint-Luc** · enrollment: 160 (estimated)

## Conditions studied

- Coronary Artery Disease
- Perioperative Bleeding

## Interventions

- **DRUG:** Oral tranexamic acid
- **DRUG:** Exacyl®
- **DRUG:** Intravenous placebo

## Key facts

- **NCT ID:** NCT07740330
- **Lead sponsor:** Clinique Saint-Luc
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2028-06
- **Final completion:** 2028-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740330, "Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07740330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*